Articles
With some interest, I have been following the Association of the British Pharmaceutical Industry (ABPI) innovation project looking at ‘Real World Data’. Just this month the ABPI launched its ‘Vision for Real World data’. One of the key drivers for the ABPIs project team overseeing this project is to better understand and define the value [...]
This month, several passionate digital strategists convened on Brighton – in spite of the looming and blustering tail of Hurricane Irene blowing in hard from the south of England. My colleague Marie-Claire Wilson has commented on the day itself, however a highlight for me was my lunch-break conversation with Miguel Tovar, a pharmacist and consultant [...]
During August 2011, the European Medicines Agency (EMA) made an announcement that they intend to open to the public the information that is currently held in their EudraVigilance and EudraVigilance Veterinary databases. Since launching in 2001, EudraVigilance has provided a mechanism for a variety of stakeholders to report suspected unexpected serious adverse reactions (SUSARs) which [...]
Few could have predicted the way in which the Internet has changed the dynamic of relationships amongst healthcare stakeholders. For the pharmaceutical industry, it seems there is an opportunity to also play a role in the many online relationships which are made possible by the Internet. Despite the Internet being completely global and respecting [...]
No one wants to be wrong; ever. As much as there are trendy business mantras such as ‘Fail Fast’ which apparently encourage failure (as long as you learn quickly), it somehow just doesn’t translate to the world of a pharmaceutical company. In fact, ‘fail-fast’ is really an engineering concept that is most often considered in [...]
In the second video instalment from the Elite Global Forum series, we hear about the nature of two-way engagement and some of the expectations of so-called ‘e-Patients’ (empowered patients). Whilst there is still some debate about the appropriate use of social media for communications, particularly by pharmaceutical companies, this episode’s thought-leaders simply think it is [...]
Creation Healthcare’s Elite Global Forum was conceived to be a no-nonsense, no-limits, global think tank. Since that time, several informal discussions have been taking place around the globe in which professionals from pharmaceutical, hospital, government and not-for-profit organizations challenge each other, share ideas, and look to break new ground in healthcare engagement. While attending conferences [...]
It was ironically only a couple of weeks ago that Creation Healthcare published a piece about “Healthcare engagement in the absence of regulatory guidance”. In that article, I made the point that “specific social media guidance cannot keep pace with change”, and more importantly that when using 3rd party engagement platforms like Facebook, Flickr or [...]
In early March 2011, at a pharmaceutical marketing conference in Munich, Heather Simmonds of the PMCPA gave very much the same perspective on UK and European regulatory guidelines that she has for the past few years. There were some murmurings amongst the crowd from those who had heard it all before. Refreshingly, at the same [...]
A relatively new software company is challenging the landscape of social media monitoring, particularly in the pharmaceutical and healthcare industry.
An extensive international study of potentially reportable adverse event mentions amongst ten major therapy areas:
Anaemia • Arthritis • Asthma • Breast Cancer • Cardiovascular • Deep Vein Thrombosis • Gastrointestinal • Mental Health • Osteoporosis • Type II Diabetes
In this second video report from Dubai, international experts in e-Health and mobile health share some thoughts from their own experiences of implementing mHealth solutions in the developing world.
In the first of a series of short videos from Dubai, experts speak about the future of mHealth.
At DigiPharm 2010, Creation Healthcare will be presenting groundbreaking research into adverse events online. In this article, Paul Grant provides a first look at brand new insights to inform your strategy.
There has been considerable discussion in recent times about ‘local’ versus ‘global’ engagement strategy, or whether there is some kind of mystical balance of the two. Earlier this year Creation Healthcare was pleased to facilitate seminars in New York and London with leading global pharmaceutical and healthcare companies, during which the constraints and opportunities of [...]
Whilst the Western world has been developing electronic medical record technologies like Google Health and Microsoft HealthVault in recent times, Taiwan’s innovative IC Card medical record system is the result of 16 years of systems integration.
In these slides, Paul Grant outlines how the Internet is changing healthcare by empowering the consumer and the e-patient. Paul looks at data and examples from the USA and Europe, and considers the impact of ratings websites, online health records, and the way in which doctors are responding to the e-patient.
In this video, we capture experiences from some of the participants. Hear experts from Benenden Healthcare Society, Boehringer Ingelheim, Doctors.net.uk, Napp Pharmaceuticals, NHS Barking & Dagenham, Pfizer, and Systagenix and discover what healthcare engagement means to them.
Perhaps you noticed some of the confusion about return on investment (ROI) for social media and online initiatives in the past year. Certainly there has been a lot of conversation online and offline about what this actually is.
‘Engagement’ was a hot topic at the ePharma Summit, then again a few days later in New York when I presented the award winning engagement strategies from the HES Awards at the Hilton Times Square….
Paul ensures that the Creation Healthcare team delivers the highest calibre of strategic services, to help our clients define and direct successful digital media initiatives with measurable results.